A search-style page about whether the FDA has approved retatrutide. The listing gives no details on any decision or timeline.
Recap by typeshit. Full story at www.polskieradio.pl.
Lilly's tirzepatide shot Zepbound now has FDA approval in a KwikPen format for weight management. Tap through for details on the new pen.
At the SIO congress in Palermo, specialists flagged short real-world adherence and no national reimbursement in Italy. Oral semaglutide and orforglipron are expected there in 2027.
Polish pharmacy platform GdziePoLek says, citing the manufacturer, that the first Oral Wegovy shipment should arrive soon. No exact launch date is set yet.
A short clip from Dr. Reese pushing back on the rush toward peptides as an easy shortcut, with little detail beyond that.
Reports say the Trump administration may let some compounding pharmacies dispense peptides not fully safety tested, and an Auckland academic is concerned.
A hype-heavy explainer on retatrutide, the Lilly drug that targets three hormone pathways at once. It doesn't add anything new on trials or approval timing.
Loading…